Goncalves et al. reviewed three steps for how PI3K pathway inhibitors can lead to sustained hyperglycemia in patients via a suppressed intracellular response to insulin: reduction in glucose uptake with glycolysis, increased glycogenolysis, and increased gluconeogenesis34. Here, INS is linked to Hyperglycemia.